Read More
Expert panel provides guidance for optimized design of early drug trials for Alzheimer's, related dementias
An expert panel convened by the Alzheimer's Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer's disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
Subscribe to:
Post Comments (Atom)
0 Response to "Expert panel provides guidance for optimized design of early drug trials for Alzheimer's, related dementias"
Post a Comment